MKI67 and breast carcinoma: Since it can be easily retrieved analyzing paraffin-embedded sections of tumor tissue, ki67 is a prognostic marker commonly used in clinical practice to determine tumor aggressiveness, and, consequently, to select the most appropriate breast cancer therapy [6].